Gastric Inhibitory Peptide (GIP), human is thought to act as an inhibitor of gastric functions.
CAT No: R1092
CAS No:100040-31-1
Synonyms/Alias:GIP (human);100040-31-1;Gastric Inhibitory Peptide (GIP), human;GIP, human;GIP human TFA;PGR-4178-V;AKOS034831552;AS-75340;PD079253;Gastric Inhibitory Peptide (GIP), human TFA;Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys- Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln; Gastric Inhibitory Polypeptide (Human) Glucose-dependent Insulinotropia Polypeptide;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.